This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lima, J. A.C. Articles by Desai, M. Y. Search for Related Content PubMed PubMed Citation Articles by Lima, J. A.C. Articles by Desai, M. Y.

STATE-OF-THE-ART PAPER

Cardiovascular magnetic resonance imaging: Current and emerging applications

Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA

Manuscript received February 11, 2004; revised manuscript received May 6, 2004, accepted June 7, 2004.

^* Reprint requests and correspondence: Dr. João A. C. Lima, Associate Professor of Medicine, Radiology, and Epidemiology, Blalock 524, Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore, Maryland 21287 (Email: jlima{at}jhmi.edu).

Magnetic resonance (MR) imaging is gaining importance in cardiology as the newest, most complex, and rapidly emerging noninvasive test of choice for patients with a multitude of cardiovascular problems. It has long been recognized to provide an accurate and reliable means of assessing the function and anatomy of the heart and great vessels, but its emerging role as one of the dominant imaging modalities in other aspects of cardiology such as perfusion imaging, atherosclerosis imaging, and coronary artery imaging cannot be understated. As MR technology evolves, newer therapeutic applications are also being developed, including specific MR-compatible catheters for electrophysiology studies/ablation as well as interventional cardiology related procedures, which may alter the way we practice cardiology in the future. Also, MR is entering an important phasein its evolution, with an anticipated exponential growth in its current applications and through the development of newer molecular imaging applications. It is anticipated that such developments will be coupled to the utilization of molecular markers to index biologic processes to allow for their in vivo visualization. This combination of biochemical markers and imaging methodology will also usher in an era of molecular imaging during which much progress in the diagnosis and treatment of cardiovascular disease is anticipated.

Abbreviations and Acronyms   DHE = delayed hyperenhancement   HCM = hypertrophic cardiomyopathy   LV = left ventricle/ventricular   LVOT = left ventricular outflow tract   MR = magnetic resonance   MRI = magnetic resonance imaging   RV = right ventricle/ventricular

This article has been cited by other articles:

				D H Kwon, N G Smedira, Z B Popovic, B W Lytle, R M Setser, M Thamilarasan, P Schoenhagen, S D Flamm, H M Lever, and M Y Desai Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging Heart, November 1, 2009; 95(21): 1784 - 1791. [Abstract] [Full Text] [PDF]

				M. S. Maron, I. Olivotto, B. J. Maron, S. K. Prasad, F. Cecchi, J. E. Udelson, and P. G. Camici The case for myocardial ischemia in hypertrophic cardiomyopathy. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 866 - 875. [Abstract] [Full Text] [PDF]

				P. G. Chan, M. P. Smith, T. H. Hauser, S. B. Yeon, E. Appelbaum, N. M. Rofsky, and W. J. Manning Noncardiac Pathology on Clinical Cardiac Magnetic Resonance Imaging J. Am. Coll. Cardiol. Img., August 1, 2009; 2(8): 980 - 986. [Abstract] [Full Text] [PDF]

				M. S. Maron, B. J. Maron, C. Harrigan, J. Buros, C. M. Gibson, I. Olivotto, L. Biller, J. R. Lesser, J. E. Udelson, W. J. Manning, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J. Am. Coll. Cardiol., July 14, 2009; 54(3): 220 - 228. [Abstract] [Full Text] [PDF]

				R. Benza, R. Biederman, S. Murali, and H. Gupta Role of Cardiac Magnetic Resonance Imaging in the Management of Patients With Pulmonary Arterial Hypertension J. Am. Coll. Cardiol., November 18, 2008; 52(21): 1683 - 1692. [Abstract] [Full Text] [PDF]

				M. S. Maron, J. J. Finley, J. M. Bos, T. H. Hauser, W. J. Manning, T. S. Haas, J. R. Lesser, J. E. Udelson, M. J. Ackerman, and B. J. Maron Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy Circulation, October 7, 2008; 118(15): 1541 - 1549. [Abstract] [Full Text] [PDF]

				D H Kwon, R M Setser, M Thamilarasan, Z V Popovic, N G Smedira, P Schoenhagen, M J Garcia, H M Lever, and M Y Desai Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Heart, October 1, 2008; 94(10): 1295 - 1301. [Abstract] [Full Text] [PDF]

				M. S. Maron, E. Appelbaum, C. J. Harrigan, J. Buros, C. M. Gibson, C. Hanna, J. R. Lesser, J. E. Udelson, W. J. Manning, and B. J. Maron Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy Circ Heart Fail, September 1, 2008; 1(3): 184 - 191. [Abstract] [Full Text] [PDF]

				J. R. Mikolich Right Ventricular Diastolic Collapse by Cardiac Magnetic Resonance Imaging Circulation, August 19, 2008; 118(8): e122 - e125. [Full Text] [PDF]

				J.-H. Lin, C.-H. Shih, K. Kaphle, L.-S. Wu, W.-Y. Tseng, J.-H. Chiu, T.-c. Lee, and Y.-L. Wu Acupuncture Effects on Cardiac Functions Measured by Cardiac Magnetic Resonance Imaging in a Feline Model Evid. Based Complement. Altern. Med., January 23, 2008; (2008) nem187v1. [Abstract] [Full Text] [PDF]

				Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]

				Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]

				C. Rickers, N. M. Wilke, M. Jerosch-Herold, S. A. Casey, P. Panse, N. Panse, J. Weil, A. G. Zenovich, and B. J. Maron Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy Circulation, August 9, 2005; 112(6): 855 - 861. [Abstract] [Full Text] [PDF]